Cytokines as Active Factors in Focal Segmental Glomerulosclerosis
- 1 January 2016
- book chapter
- Published by Springer Nature
- p. 155-178
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Resolution of Recurrent Focal Segmental Glomerulosclerosis after RetransplantationNew England Journal of Medicine, 2012
- Focal Segmental GlomerulosclerosisNew England Journal of Medicine, 2011
- A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisKidney International, 2011
- Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study GroupAmerican Journal of Kidney Diseases, 2010
- Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (Palb)American Journal of Physiology-Renal Physiology, 2009
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- Proteinuria in rats induced by serum from patients with collapsing glomerulopathyKidney International, 2004
- Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in childrenAmerican Journal of Kidney Diseases, 1999
- Tumor necrosis factor alpha and mesangial cellsKidney International, 1992
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisoneThe Journal of Pediatrics, 1981